Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NeuroVive Pharmaceutical AB | 4,151,838 | net | 10 Feb 2025 | tx 112+7,401,838−3,250,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Feb 2025 | SALE | NeuroVive Pharmaceutical AB | 2,250,000 | 0.45 SEK | |
| 10 Feb 2025 | SALE | NeuroVive Pharmaceutical AB | 1,000,000 | 0.05 SEK | deriv |
| 28 May 2024 | GRANT_AWARD | NeuroVive Pharmaceutical AB | 1,000,000 | 0.03 SEK | deriv |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 38,000 | 0.21 SEK | anomaly |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 54,128 | 0.22 SEK | anomaly |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 1,000 | 0.22 SEK | anomaly |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 15,091 | 0.22 SEK | |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 11,254 | 0.22 SEK | |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 36,064 | 0.22 SEK | anomaly |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 11,901 | 0.22 SEK | |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 1,940 | 0.22 SEK | anomaly |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 11,247 | 0.22 SEK | |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 7,078 | 0.22 SEK | |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 11,275 | 0.22 SEK | |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 11,270 | 0.22 SEK | |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 11,225 | 0.22 SEK | |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 11,168 | 0.22 SEK | |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 11,251 | 0.22 SEK | |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 11,525 | 0.22 SEK | |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 11,209 | 0.22 SEK | |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 11,224 | 0.22 SEK | |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 11,265 | 0.22 SEK | |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 161,792 | 0.22 SEK | anomaly |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 1,000 | 0.22 SEK | anomaly |
| 13 Jul 2023 | PURCHASE | NeuroVive Pharmaceutical AB | 22,184 | 0.22 SEK | anomaly |